CDR3 spectratyping identifies clonal expansion within T-cell subpopulations that demonstrate therapeutic antitumor activity
- 1 August 2004
- Vol. 136 (2) , 295-302
- https://doi.org/10.1016/j.surg.2004.05.003
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Generation of Tumor-Infiltrating Lymphocyte Cultures for Use in Adoptive Transfer Therapy for Melanoma PatientsJournal of Immunotherapy, 2003
- Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by Vβ CDR3 spectratyping and flow cytometryBlood, 2002
- Clonotypic Structure of the Human CD4+ Memory T Cell Response to CytomegalovirusThe Journal of Immunology, 2001
- Helper-Independent, L-Selectinlow CD8+ T Cells with Broad Anti-Tumor Efficacy Are Naturally Sensitized During Tumor ProgressionThe Journal of Immunology, 2000
- Large clonal expansions of human virus‐specific memory cytotoxic T lymphocytes within the CD57+ CD28– CD8+ T‐cell populationImmunology, 1999
- Stability and Diversity of T Cell Receptor Repertoire Usage during Lymphocytic Choriomeningitis Virus Infection of MiceThe Journal of Experimental Medicine, 1998
- Purification of L-Selectinlow Cells Promotes the Generation of Highly Potent CD4 Antitumor Effector T LymphocytesThe Journal of Immunology, 1998
- Analysis of T cell receptor beta chain CDR3 size using RNA extracted from formalin fixed paraffin wax embedded tissue.Journal of Clinical Pathology, 1997
- The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments.Proceedings of the National Academy of Sciences, 1993
- Activation by anti-CD3 of tumor-draining lymph node cells for specific adoptive immunotherapyCellular Immunology, 1991